# Levothyroxine Sodium

NDC: 63323-648
Generic name: LEVOTHYROXINE SODIUM ANHYDROUS
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20110624

FDA application: NDA202231

## Active ingredients

- LEVOTHYROXINE SODIUM ANHYDROUS: 500 ug/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-648"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-648
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ce990712-49c1-4f66-9ee4-c770e8ec394c